Ustekinumab (Subcutaneous Route)

Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Ustekinumab (Subcutaneous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Stelara

Description

Ustekinumab is used to treat moderate-to-severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) or other treatments.

This medicine is to be administered only by or under the immediate supervision of your doctor.

Before Using
DR603075 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2012 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger